Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and sevelamer for coronary calcification in chronic kidney disease
RBR-6pngwzPhase 4Unknown
- Sponsor
- Federal University of São Paulo
- Start
- Jul 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of rosuvastatin and sevelamer carbonate in chronic kidney disease (CKD) and Coronary artery calcification (CAC) (3 arms), sponsored by Federal University of São Paulo. Status: unknown.
02
Drugs
rosuvastatinsevelamer carbonate
03
Conditions
chronic kidney disease (CKD)Coronary artery calcification (CAC)
Beyond the preview
Go deeper on RBR-6pngwz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6pngwz.